iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Advent gets Cabinet’s green signal to acquire Suven Pharma for Rs 9,589 crore

14 Sep 2023 , 11:45 AM

The Cabinet Committee on Economic Affairs, chaired by Prime Minister Narendra Modi, accepted an FDI proposal for up to Rs 9,589 crore in Suven Pharmaceuticals Limited by private equity company Advent International through its Cyprus-based Berhyanda Ltd.

In December last year, Advent International signed a definitive agreement to acquire a 50.1% stake in Hyderabad-based Suven Pharmaceuticals, a listed contract research and manufacturing services (CRAMS) firm promoted by Venkat Jasti and his family members, for Rs 6,313 crore, or Rs 495 per share.

In addition, Advent will conduct an open offer for an additional 26% of the company.

According to a government announcement, total foreign investment in Suven Pharmaceuticals may go upto 90.1%.

According to the statement, authorisation was granted after the proposal was reviewed by the relevant departments, including the RBI and SEBI, and is subject to compliance with all applicable rules and regulations.

The whole investment in Berhyanda is held by Advent Funds, which pool investments from multiple Limited Partners (LPs). Advent International Corporation, based in the United States, manages the Advent Funds.

The approved investment intends to create new jobs and expand the Indian company’s capacity through investments in plant and equipment.

For feedback and suggestions, write to us at editorial@iifl.com

explored-media

Related Tags

  • Advent International
  • Suven Pharma
  • Suven Pharma news
  • Suven Pharma Sale
  • Suven Pharma Stock
  • Suven Pharma Updates
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.